Physician profile
Ashby Jordan
NPI 1326031436
$1,341.53
in general payments reported to CMS, 2019-2025
14 companies · $19.22 in 2025
The $19.22 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $564 · 2020: $128 · 2021: $254 · 2022: $314 · 2023: $63.10 · 2025: $19.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $564.42 | 2019-2023 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.36 | 2019-2022 | |
| Glaxosmithkline, LLC. | $201.67 | 2019-2020 | |
| Inspire Medical Systems, INC. | $63.39 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $61.79 | 2019 | |
| Philips North America LLC | $47.27 | 2021 | |
| Genentech USA, INC. | $42.48 | 2019-2020 | |
| Genzyme Corporation | $28.79 | 2019 | |
| Electromed, INC. | $27.66 | 2019 | |
| Mylan Specialty L.P. | $23.82 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $23.43 | 2021 | |
| Grifols USA, LLC | $19.21 | 2020 | |
| Amgen INC. | $18.74 | 2021 | |
| Sunovion Pharmaceuticals INC. | $14.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashby Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.